We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,725 hedge funds and large institutions have $233B invested in Johnson & Johnson in 2019 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 1,041 increasing their positions, 1,352 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less funds holding

Funds holding: 2,7562,725 (-31)

4.6% less ownership

Funds ownership: 72.98%68.38% (-4.6%)

7% less capital invested

Capital invested by funds: $252B → $233B (-$18.5B)

11% less call options, than puts

Call options by funds: $1.71B | Put options by funds: $1.91B

11% less first-time investments, than exits

New positions opened: 91 | Existing positions closed: 102

23% less repeat investments, than reductions

Existing positions increased: 1,041 | Existing positions reduced: 1,352

24% less funds holding in top 10

Funds holding in top 10: 639485 (-154)

Holders
2,725
Holders Change
-31
Holders Change %
-1.12%
% of All Funds
59.75%
Holding in Top 10
485
Holding in Top 10 Change
-154
Holding in Top 10 Change %
-24.1%
% of All Funds
10.63%
New
91
Increased
1,041
Reduced
1,352
Closed
102
Calls
$1.71B
Puts
$1.91B
Net Calls
-$203M
Net Calls Change
+$4.99M
Name Holding Trade Value Shares
Change
Change in
Stake
NERM
1201
New England Research & Management
Illinois
$4.49M +$250K +1,900 +6%
SCP
1202
Shorepoint Capital Partners
Massachusetts
$4.45M -$472K -3,585 -9%
ANBT
1203
American National Bank & Trust
Texas
$4.44M -$636K -4,830 -12%
RCM
1204
Radnor Capital Management
Pennsylvania
$4.44M -$19.8K -150 -0.4%
CHC
1205
City Holding Co
West Virginia
$4.44M +$21.2K +161 +0.5%
DAM
1206
Delta Asset Management
Tennessee
$4.44M +$54.8K +416 +1%
PWM
1207
Perigon Wealth Management
California
$4.44M -$866K -6,571 -16%
OBGC
1208
O'Brien Greene & Co
Pennsylvania
$4.42M -$219K -1,660 -5%
JMH
1209
J.M. Hartwell
New York
$4.42M +$232K +1,759 +5%
AC
1210
Addenda Capital
Quebec, Canada
$4.42M -$16.2K -123 -0.4%
EWM
1211
Endurance Wealth Management
Rhode Island
$4.4M -$47.2K -358 -1%
RWM
1212
Rench Wealth Management
Texas
$4.4M +$244K +1,853 +6%
NG
1213
Northstar Group
New York
$4.4M -$232K -1,758 -5%
JCM
1214
Jacobi Capital Management
Pennsylvania
$4.39M +$316K +2,396 +8%
DF
1215
Donoghue Forlines
Massachusetts
$4.34M -$1.52M -11,544 -26%
KFP
1216
Keystone Financial Planning
Ohio
$4.34M +$263K +1,994 +6%
CAM
1217
Cresset Asset Management
Illinois
$4.33M +$521K +3,951 +13%
WA
1218
Wasatch Advisors
Utah
$4.33M +$2.17M +16,498 +97%
CQS
1219
Credential Qtrade Securities
$4.33M +$70.7K +537 +2%
CIM
1220
Cambria Investment Management
California
$4.3M +$57.7K +438 +1%
MHIM
1221
MacNealy Hoover Investment Management
Ohio
$4.3M -$566K -4,296 -11%
LPT
1222
Legacy Private Trust
Wisconsin
$4.27M -$852K -6,468 -16%
LCM
1223
Lucas Capital Management
New Jersey
$4.27M -$750K -5,695 -15%
CCM
1224
Cadence Capital Management
Massachusetts
$4.26M -$274K -2,076 -6%
ST
1225
Somerset Trust
Pennsylvania
$4.26M -$59.2K -449 -1%

JNJ Hedge Fund Activity: Q3 2019 in Review

2,725 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2019, worth a combined $233B — down 7.4% from $252B a quarter earlier.

Sellers outnumbered buyers: 102 funds closed out of JNJ and 91 opened new positions — a net loss of 11 holders — while 1,352 trimmed existing stakes and 1,041 added.

The largest buyer was Wellington Management Group, adding an estimated $304M. The largest seller was Phocas Financial Corp, cutting an estimated $16.5B.

  • 2,725 institutional investors held Johnson & Johnson (JNJ) as of Q3 2019, down from 2,756 in Q2 2019.
  • Funds reported $233B of Johnson & Johnson stock for Q3 2019, down 7.4% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q3 2019 and 102 closed out, a net change of -11 holders.
  • The largest Johnson & Johnson buyer in Q3 2019 was Wellington Management Group, an estimated $304M added.
  • The largest Johnson & Johnson seller in Q3 2019 was Phocas Financial Corp, an estimated $16.5B sold.

Based on aggregated 13F filings for Q3 2019.